The Flamma Group, a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late-stage ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

Cellular Origins, the Cell and Gene Therapy Catapult, and Resolution Therapeutics have formed a consortium funded by Innovate ...